Form D · Pharmaceuticals

BICYCLE THERAPEUTICS PLC

Cambridge, X0 · CIK 0001761612

Offering snapshot reported Jun 12, 2024 · SEC filing

Reported sold
$555M
Offering amount: $555M
Investors reported
19
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
May 28, 2024
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jun 12, 2024Initial$555,499,983No comparison19SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$10.1M
Finders' fees
$0
Form D file number
021-515738

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
JEFFERIES LLC2347

Source: Form D, filed Jun 12, 2024. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Santiago Arroyo Executive
Felix J. Baker Director
Janice Bourque Director
Nigel Crockett Executive
Jose Carlos Gutierrez Ramos Director
Michael Hannay Executive
Nicholas Keen Executive
Richard N. Kender Director
Kevin Lee Director, Executive
Pierre Legault Director
Alistair Milnes Executive
Stephen Sands Director
Michael Skynner Executive
Gregory Winter Director
Alethia Young Executive

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
Blocks A & B, Portway Building Granta Park, Great Abington
Cambridge, X0, CB21 6GS